These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3379027)

  • 21. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 22. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
    Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
    Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of psychiatrists' practices related to the use of tricyclic antidepressants.
    Goldberg SC; Tilley DH; Friedel RO; Hamer RM; Ban TA
    Hosp Community Psychiatry; 1986 Dec; 37(12):1247-51. PubMed ID: 3804226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children.
    Preskorn SH; Weller E; Hughes C; Weller R
    Clin Neuropharmacol; 1986; 9 Suppl 4():265-7. PubMed ID: 3552217
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic monitoring of treatment with antidepressants.
    Bourin MS; Kergueris MF; Lapierre YD
    Psychiatr J Univ Ott; 1989 Sep; 14(3):460-2. PubMed ID: 2678187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
    Chan CH; Janicak PG; Davis JM; Altman E; Andriukaitis S; Hedeker D
    J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing practices in Britain.
    Bramble D
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):1-2. PubMed ID: 7860448
    [No Abstract]   [Full Text] [Related]  

  • 33. Behavioral effects of tricyclic drugs in depressed inpatients.
    Lyons JS; Rosen AJ; Dysken MW
    J Consult Clin Psychol; 1985 Feb; 53(1):17-24. PubMed ID: 3980824
    [No Abstract]   [Full Text] [Related]  

  • 34. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 35. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants.
    Perry W; Viglione DJ
    J Pers Assess; 1991 Jun; 56(3):487-501. PubMed ID: 1865307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricyclic antidepressants for children with cancer.
    Pfefferbaum-Levine B; Kumor K; Cangir A; Choroszy M; Roseberry EA
    Am J Psychiatry; 1983 Aug; 140(8):1074-6. PubMed ID: 6869596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of low-dose tricyclic antidepressants for children with functional gastrointestinal disorders.
    Teitelbaum JE; Arora R
    J Pediatr Gastroenterol Nutr; 2011 Sep; 53(3):260-4. PubMed ID: 21865971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant treatment of children: clinical relapse is unrelated to tricyclic plasma concentrations.
    Olig RM; Staton RD; Beatty WW; Wilson H; Biberdorf RI; Hoag SG; Brumback RA
    Percept Mot Skills; 1985 Jun; 60(3):879-89. PubMed ID: 4022736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative effectiveness of detoxification hemosorption and electroconvulsive therapy in patients with endogenous depression resistant to tricyclic antidepressants].
    Kosov NE; Mosolov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):74-8. PubMed ID: 1650104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness.
    Staton RD; Wilson H; Brumback RA
    Percept Mot Skills; 1981 Aug; 53(1):219-34. PubMed ID: 7290870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.